Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection.
暂无分享,去创建一个
Mingyu Chen | Bin Zhang | Win Topatana | Jiasheng Cao | Shijie Li | Jiahao Hu | S. Peng | Xiujun Cai | Ziyi Lu | Tian-Bin Chen | Sarun Jeungpanich | Jiafei Yan
[1] D. Stocken,et al. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] K. Hemminki,et al. Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast , 2022, International journal of cancer.
[3] Yoo-Seok Yoon,et al. Comparative Study of Laparoscopic Versus Open Liver Resection in Gallbladder Cancer. , 2021, Journal of laparoendoscopic & advanced surgical techniques. Part A.
[4] Xiujun Cai,et al. Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer , 2021, Frontiers in Oncology.
[5] J. W. Kim,et al. A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy. , 2021, European journal of cancer.
[6] W. Lau,et al. Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit , 2021, Frontiers in Oncology.
[7] S. Raman,et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[8] Hong-Mei Yu,et al. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. , 2021, Surgery.
[9] A. Zhu,et al. Biliary tract cancer , 2021, The Lancet.
[10] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[11] G. Molina,et al. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers , 2020, JAMA network open.
[12] Fei Liu,et al. Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China , 2020, Surgical Endoscopy.
[13] Ying-bin Liu,et al. Overview of current targeted therapy in gallbladder cancer , 2020, Signal Transduction and Targeted Therapy.
[14] W. Bemelman,et al. Safe, selective histopathological examination of gallbladder specimens: a systematic review , 2020, The British journal of surgery.
[15] R. Coriat,et al. The choice for the optimal therapy in advanced biliary tract cancers: Chemotherapy, targeted therapies or immunotherapy. , 2020, Pharmacology & therapeutics.
[16] J. Vauthey,et al. Comparison of oncological outcomes after open and laparoscopic re‐resection of incidental gallbladder cancer , 2019, The British journal of surgery.
[17] W. Harmsen,et al. Impact of delay to surgery on survival in stage I-III colon cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[18] J. D'haese,et al. Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox , 2019, Journal of Cancer Research and Clinical Oncology.
[19] R. Makuuchi,et al. Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[20] Qiuran Xu,et al. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. , 2019, Annals of translational medicine.
[21] Prashanth Rawla,et al. Epidemiology of gallbladder cancer , 2019, Clinical and experimental hepatology.
[22] J. Raftery,et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.
[23] A. Khorana,et al. Time to initial cancer treatment in the United States and association with survival over time: An observational study , 2019, PloS one.
[24] R. Makuuchi,et al. Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer , 2018, Gastric Cancer.
[25] M. Kojima,et al. The prognostic impact of differentiation at the invasive front of biliary tract cancer , 2018, Journal of surgical oncology.
[26] T. Pawlik,et al. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers , 2018, Annals of Surgical Oncology.
[27] A. Zhu,et al. New Horizons for Precision Medicine in Biliary Tract Cancers. , 2017, Cancer discovery.
[28] Jeffrey E. Lee,et al. Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer , 2017, Annals of Surgical Oncology.
[29] K. Kawamoto,et al. Laparoscopic approach to suspected T1 and T2 gallbladder carcinoma , 2017, World journal of gastroenterology.
[30] T. Pawlik,et al. Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium , 2017, JAMA surgery.
[31] S. Shrikhande,et al. Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma , 2016, Journal of surgical oncology.
[32] Z. Lou,et al. CT pelvimetry and clinicopathological parameters in evaluation of the technical difficulties in performing open rectal surgery for mid-low rectal cancer , 2015, Oncology letters.
[33] Eun Sun Lee,et al. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma , 2015, Abdominal Imaging.
[34] V. Sreenivas,et al. Risk factors for gallbladder cancer: A case–control study , 2013, International journal of cancer.
[35] I. Choi,et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] E. Shaffer,et al. Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer , 2012, Gut and liver.
[37] I. Ikai,et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: “narrow pelvis” is not a contraindication , 2011, Surgical Endoscopy.
[38] C. Ko,et al. Wait Times for Cancer Surgery in the United States: Trends and Predictors of Delays , 2011, Annals of surgery.
[39] J. Llamas-Elvira,et al. Application of modern imaging methods in diagnosis of gallbladder cancer , 2006, Journal of surgical oncology.
[40] T. Oshikiri,et al. Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.